Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04003103
Recruitment Status : Active, not recruiting
First Posted : July 1, 2019
Last Update Posted : April 8, 2022
Information provided by (Responsible Party):
Merck Sharp & Dohme LLC

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 18, 2022
Estimated Study Completion Date : March 30, 2023